v3.25.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2023
Cash Flows from Operating Activities      
Net earnings (loss) $ 30,057 $ (158,764) $ (259,458)
Adjustments to reconcile net earnings (loss) to net cash provided by operating activities:      
Depreciation 250,810 271,601 267,562
Amortization 302,788 288,160 414,125
Share-based compensation expense 160,239 126,049 148,872
Non-cash restructuring and impairment charges 140,912 16,557 119,456
Amortization of discount on convertible debt and debt issuance costs 19,774 17,652 19,850
Losses on disposals of property, plant & equipment 782 758 2,440
Unrealized losses (gains) on foreign currency remeasurements and transactions 33,122 (10,556) (3,549)
Loss (earnings) from equity investments (1,316) 51 66
Deferred income taxes (95,434) (112,096) (206,822)
Loss on debt extinguishment 0 1,978 6,855
Increase (decrease) in cash from changes in (net of effects of acquisitions):      
Accounts receivable (170,444) 60,581 68,315
Inventories (202,728) (23,196) 174,136
Accounts payable 217,357 205,044 (83,330)
Contract liabilities 3,182 (72,818) (18,957)
Income taxes (22,118) 12,251 28,651
Accrued compensation and benefits 62,960 36,894 (60,595)
Other operating net assets (liabilities) (96,343) (114,415) 16,408
Net cash provided by operating activities 633,600 545,731 634,025
Cash Flows from Investing Activities      
Additions to property, plant & equipment (440,836) (346,816) (436,060)
Purchases of businesses, net of cash acquired 0 0 (5,488,556)
Proceeds from the sale of business 27,000 0 0
Other investing activities (379) (3,897) (4,010)
Net cash used in investing activities (414,215) (350,713) (5,928,626)
Cash Flows from Financing Activities      
Sale of shares to noncontrolling interests 0 1,000,000 0
Proceeds from issuance of Series B preferred shares 0 0 1,400,000
Proceeds from borrowings of revolving credit facilities 53,729 18,966 65,000
Payments on existing debt (436,986) (228,802) (1,265,175)
Payments on borrowings under Revolving Credit Facilities (51,661) (19,027) (65,000)
Payments on convertible notes 0 0 (3,561)
Debt issuance costs 0 0 (126,516)
Equity issuance costs 0 (31,840) (42,000)
Proceeds from exercises of stock options and purchases of stock under employee stock purchase plan 49,570 42,297 24,167
Payments in satisfaction of employees’ minimum tax obligations (53,992) (22,315) (54,172)
Cash dividends paid (11,438) 0 (27,600)
Other financing activities (948) (1,007) (1,124)
Net cash provided by (used in) financing activities (451,726) 758,272 3,554,019
Effect of exchange rate changes on cash, cash equivalents, and restricted cash 75,568 (1,170) (4,223)
Net increase in cash and cash equivalents, and restricted cash (156,773) 952,120 (1,744,805)
Cash, Cash Equivalents, and Restricted Cash at Beginning of Period 1,789,686 837,566 2,582,371
Cash, Cash Equivalents, and Restricted Cash at End of Period 1,632,913 1,789,686 837,566
Supplemental Information      
Cash paid for interest 256,704 312,879 282,835
Cash paid for income taxes 166,849 97,295 89,567
Non-Cash Investing and Financing Activities:      
Additions to property, plant & equipment included in accounts payable 67,146 63,286 36,777
Conversion of Series A preferred stock to common stock 0 445,319 0
Reconciliation of Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents      
Cash and cash equivalents 909,200 926,033 821,310
Restricted cash, current 8,897 174,008 12,023
Restricted cash, non-current 714,816 689,645 4,233
Total cash, cash equivalents, and restricted cash shown in the consolidated statements of cash flows 1,632,913 1,789,686 837,566
Term B Facility      
Cash Flows from Financing Activities      
Proceeds from borrowing of Term Facility 0 0 2,800,000
Term A Facility      
Cash Flows from Financing Activities      
Proceeds from borrowing of Term Facility $ 0 $ 0 $ 850,000